Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial
Author:
Michael D. Ezekowitz,Charles V. Pollack,Paul Sanders,Jonathan L. Halperin,Judith Spahr,Nilo Cater,William Petkun,Andrei Breazna,Paulus Kirchhof,Jonas Oldgren
Publication:
American Heart Journal
© 2016 The Authors. Published by Elsevier Inc.